News
Melanoma incidence is up, but death rates are down
“This is very encouraging data and represents the real-world effectiveness of these therapies.”
News
Are pain meds the only option for chronic pain in cirrhosis?
An emphasis on nonpharmacologic approaches, such as diet and psychological interventions, can sometimes handle even less familiar sources of pain...
News
Baclofen shows limited role in GERD
The drug showed benefit in PPI refractory symptoms for patients with non-acid reflux.
News
Liver-related telehealth faces tech barriers
Rural and underserved areas may lack the technology needed to access innovative care solutions.
News
Metastatic lobular, ductal cancers respond similarly
Lobular cancers differ physiologically, but trial results generally apply to ductal tumors.
News
Neighborhood analysis links breast cancer outcomes to socioeconomic status
“This study should make clinicians cognizant of the potential for biases in management of metastatic breast cancer in terms of socioeconomic...
News
Autoimmune disease linked to better late-stage breast cancer survival
Retrospective data hint at antitumor activity, but other explanations are possible
News
Breast cancer deaths take a big dip because of new medicines
Research model suggests a 58% overall mortality decline in 2019 from metastatic breast cancer.
News
Pseudocirrhosis in breast cancer may signal liver metastases
A better understanding of this common comorbidity could lead to better management and treatment.
News
New treatment outperforms chemo in HER2-low breast cancer
The results may cause clinicians to reconsider how they define HER2 expression in breast cancer.
News
New treatment meets unmet need in breast cancer
Expert calls advance incremental, but clinically important for women with HR positive/HER2 negative breast cancer.
News
ctDNA spots breast cancer recurrence
Personalized surveillance technique has the potential to augment adjuvant therapy and improve long-term outcomes.
News
mTOR inhibitor shows early promise in endometrial cancer
The combination led to reduced progression with good tolerability in metastatic, hormone receptor–positive patients.
News
Immunotherapy treatment combo charts new course for resectable NSCLC treatment
Three cycles of neoadjuvant nivolumab plus chemotherapy improved long-term clinical outcomes in resectable stage IB-IIIA NSCLC.
News
Neoadjuvant denosumab ineffective in breast cancer
Trial returns a negative result for the RANKL inhibitor, but identifies favored schedule for nab-paclitaxel.